How Cell and Gene Manufacturers Can Scale to Meet Demand

Between 2022 and 2030, the cell and gene therapy sector is expected to experience a compound annual growth rate (CAGR) of 39.42 percent, BioSpace said of a recent Vision Research Report.

This is quite a large anticipated growth; how will startups and current manufacturing companies work to meet this growing demand?

On today’s episode of Exceeding Your Benchmark, Host Sumit Verma, Senior Vice President, Global Strategic Manufacturing at Iovance Biotherapeutics, addresses cell and gene therapy industry trends and challenges and what manufacturers can do to promote growth in the sector.

Verma also discussed…

  1. The greatest challenges biopharma startups face
  2. How established CGT manufacturers are preparing to meet an increased demand
  3. What place automation has in advanced cell manufacturing

Verma believes there are three key areas manufacturers need to target to help supply meet increasing demand. “I think most players are focusing on three big things: one is around scalability, the second is around supply chain, making sure we have all the components, and last is about talent. Verma said of the talent piece, “There aren’t many people who have advanced programs for therapeutic manufacturing today…there are a lot of synergies and the big pharma have done a great job establishing developing programs that are very supportive of their large plants and their scalable efforts and we’ve seen the need to do that in cell and gene therapy.

Recent Episodes

Healthcare access
View episode

Healthcare costs are rising steadily, while insurance benefits struggle to offer sufficient coverage, driving demand for practical solutions like nontraditional benefits and discount plans. As premiums rise and coverage limits remain stagnant, many individuals and employers seek alternative ways to manage costs and improve healthcare access. With chronic conditions on the rise, the stakes…

rule
View episode

The 2025 Home Health Final Rule introduces a range of regulatory updates to improve transparency, elevate patient care standards, and stabilize financial practices within the home health sector. With these updates taking effect, home health agencies must adapt quickly, especially as CMS focuses on value-based care and Social Determinants of Health (SDOH). According to…

View episode

The significance of excellent customer service in every corner and industry cannot be overstated. This notion is especially crucial in healthcare, where patient experiences often influence their recovery and overall well-being. The topic of customer service in the medical field is always a priority in healthcare because providers strive to enhance patient satisfaction and…